Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH)

Kanuni Sultan Suleyman Training and Research Hospital88 enrolled

Overview

Anti-Mullerian hormone (AMH) is a marker for ovarian reserve. There are many studies about AMH changes in ovarian surgery, but little is known for other surgeries. We seek to investigate the hormone variations before and after uterine artey ligation for postpartum hemorrage (PPH)

All patients belong to the same group. The blood samples will be collected at the time of surgery and 3 months after surgery from the patients who need uterine artery ligation for PPH. The blood samples will be centrifuged within 2 hours after being obtained and assessed on the same day. AMH concentrations will be measured with an enzymatically amplified two-sided immunoassay

Study Type

OBSERVATIONAL

Enrollment

Conditions

Anti-Mullerian Hormone Deficiency Post Partum Hemorrhage

Interventions

anti- mullerian hormoneOTHER

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * age 18- 40 years * no systemic or endocrine diseases * patients who had uterine artery ligation due to PPH Exclusion Criteria: * Pregnancy with IVF or oosit donation * Patients with endocrinopathy, diseases which require radiotherapy and chemotherapy etc. * Patients with BMI \>40

Outcomes

Primary Outcomes

1- Anti-Mullerian Hormone levels variation

Anti-Mullerian Hormone levels before and 3 months after surgery

Time frame: 3 months